Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03519178
Title A Safety, Pharmacokinetic, Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Pfizer

ovary epithelial cancer

Her2-receptor negative breast cancer

triple-receptor negative breast cancer

peritoneum cancer

fallopian tube cancer



Age Groups: adult
Covered Countries USA

No variant requirements are available.